The invention relates to a profile extrusion process for producing fashioned animal food, especially dog chew bones, the process comprising the following steps: loading an extruder with casein, a plasticizer and with additives; preparing a plasticized casein compound containing 10 to 80% casein by weight, wherein the casein and the plasticizer are subject to a mechanical strain at a temperature below 130° C. in the extruder; molding the casein compound into a profile, wherein the casein compound is pressed through the extruder nozzle onto a transfer device and is consolidated on said transfer device; curing the profile, wherein the profile is cooled on the transfer device; portioning the profile into portions of any length, wherein the profile is cut at a corresponding position using a cutting tool.

Disclosed are bolus compositions for use in the treatment or prevention of hypocalcemia and choline deficiency in ruminants. The bolus compositions may comprise rumen-protected choline, one or more calcium salts, and water.

One compound (100) according to the present invention contains silicon fine particles having a capability of generating hydrogen or aggregates of the silicon fine particles. The compound that contains the silicon fine particles or the aggregates having a capability of generating hydrogen is capable of generating hydrogen in the body of, for example, an animal that has ingested the compound. For a plant, the compound can be disposed or charged into, for example, moisture (water-containing liquid) or fertilizer to be provided to the plant, to supply the plant with hydrogen generated from the compound.

The invention relates to a method for producing, amongst other things, amino-acid and/or hydroxycarboxylic-acid metal chelates, a solvent-free mixture of at least one metal oxide, metal hydroxide, metal carbonate or oxalate, and the solid organic acid is subjected to intensive mechanical stress. According to the invention, this is done in that the reaction partners are introduced in particle form into a fluid stream of a fluid-bed countercurrent mill operating without grinding elements, wherein mechanical activation of at least one of the reaction partners is effected by collision processes within a reaction chamber formed in a region of the fluid stream, and a solid body reaction to form the metal chelate is triggered. The novel method operates very energy-efficiently and with a high specific yield. It leads to a product having compact particles in the small, single-digit micrometer range having a comparatively narrow particle size distribution and a large surface. The product is homogenous and very pure. Thermal loading or decomposition of the organic chelate ligands, in particular of the amino acids, is likewise avoided, as are contaminants from milling and grinding element abrasion.

The invention relates to a method for producing, amongst other things, amino-acid and/or hydroxycarboxylic-acid metal chelates, a solvent-free mixture of at least one metal oxide, metal hydroxide, metal carbonate or oxalate, and the solid organic acid is subjected to intensive mechanical stress. According to the invention, this is done in that the reaction partners are introduced in particle form into a fluid stream of a fluid-bed countercurrent mill operating without grinding elements, wherein mechanical activation of at least one of the reaction partners is effected by collision processes within a reaction chamber formed in a region of the fluid stream, and a solid body reaction to form the metal chelate is triggered. The novel method operates very energy-efficiently and with a high specific yield. It leads to a product having compact particles in the small, single-digit micrometer range having a comparatively narrow particle size distribution and a large surface. The product is homogenous and very pure. Thermal loading or decomposition of the organic chelate ligands, in particular of the amino acids, is likewise avoided, as are contaminants from milling and grinding element abrasion.

Provided in the present disclosure is a mixture, comprising 86-89 wt % of a methionine hydroxy analog and an oligomer thereof, more than 99.95 wt % being a monomer, dimer and trimer, and the ratio of monomer:dimer:trimer by weight being 77-80:18.5-19.5:3-4; 9.2-13.5 wt % of water; and less than 0.5 wt % of ammonium sulfate and ammonium bisulfate. The viscosity of the mixture at 10° C. is lower than 200 mPa.Math.s. Further provided is a method for processing a mixture containing a methionine hydroxy analog and an oligomer thereof.

Provided in the present disclosure is a mixture, comprising 86-89 wt % of a methionine hydroxy analog and an oligomer thereof, more than 99.95 wt % being a monomer, dimer and trimer, and the ratio of monomer:dimer:trimer by weight being 77-80:18.5-19.5:3-4; 9.2-13.5 wt % of water; and less than 0.5 wt % of ammonium sulfate and ammonium bisulfate. The viscosity of the mixture at 10° C. is lower than 200 mPa.Math.s. Further provided is a method for processing a mixture containing a methionine hydroxy analog and an oligomer thereof.

Compositions and methods are disclosed for providing a pet food feeding system or packaged product containing multiple formulations meeting a number of parameters in order to offer diversified ingredients and varied flavors to a pet with minimized digestive stress due to dietary changes.

Compositions and methods are disclosed for providing a pet food feeding system or packaged product containing multiple formulations meeting a number of parameters in order to offer diversified ingredients and varied flavors to a pet with minimized digestive stress due to dietary changes.

A nutritionally complete animal food including, vitamins, and minerals to sustain the animal's health and wellness. The one or more ingredients containing cannabinoids added to the nutritionally complete animal food at the time of manufacturing. These cannabinoids are selected from the group consisting of Cannabichromenic acid (CBCA), Cannabidiolic acid (CBDA), Cannabidivarinic acid (CBDVA), Cannabigerolic acid (CBGA), Cannabinolic acid (CBNA), Δ9-Tetrahydrocannabinolic acid (THCA), Tetrahydrocannabinolic acid (THCVA) and combinations thereof. The concentrations of each of the cannabinoids are each less than 100 parts per million (ppm) in the at least one ingredient. In an alternate embodiment, the one or more ingredients have cannabinoids include in an aggregate concentration of less than 100 parts per million (ppm).